Shire loads up with loans for NPS Pharma takeover
Shire has raised over $3bn in loans in the last month for its $5.2bn takeover of NPS Pharma. The bio-pharmaceutical company is paying a high premium for NPS’s assets, but Shire may also be loading up on debt to deter takeover bids from rivals, said bankers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts